1Department of Molecular and Experimental Medicine, Research Institute of Scripps Clinic, La Jolla, CA 92037.
Low-dose enzyme replacement therapy using mannose-terminated glucocerebrosidase (Ceredase) showed significant improvements in liver and lung function for Gaucher disease patients. Skeletal manifestations, however, remained unchanged in this study.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background: